Home › Research › Topics › ginkgo-biloba
ginkgo-biloba
5 studies tagged ginkgo-biloba, dated 2001-09-01 to 2025-03-11. Bibliography: BibTeX (.bib) · RIS (.ris)
Newest in this topic
- Efficacy of Ginkgo biloba as an adjunct to donepezil in amyloid PET-positive Alzheimer's patients 2025-03-11
- Current Perspectives on the Beneficial Role of Ginkgo biloba in Neurological and Cerebrovascular Disorders 2015-11-09
- Long-term use of standardised Ginkgo biloba extract for the prevention of Alzheimer's disease (GuidAge): a randomised placebo-controlled trial 2012-09-06
Studies
5 studies carry this tag.
Date range
2001 to 2025
Top journals
- Alternative therapies in health and medicine 1
- Contemporary clinical trials 1
- Frontiers in neurology 1
- Integrative medicine insights 1
- The Lancet. Neurology 1
Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.
-
53/100
The addition of Ginkgo to donepezil may yield superior cognitive outcomes and a greater decrease in plasma MDS-Oaβ compared with donepezil alone in amyloid PET-positive AD patients.
-
Ginkgo biloba extract is an alternative medicine available as a standardized formulation, EGb 761(®), which consists of ginkgolides, bilobalide, and flavonoids.
-
Between March, 2002, and November, 2004, we enrolled and randomly allocated 2854 participants, of whom 1406 received at least one dose of ginkgo biloba extract and 1414 received at least one dose of placebo.
-
The epidemic of late life dementia, prominence of use of alternative medications and supplements, and initiation of efforts to determine how to prevent dementia have led to efforts to conduct studies aimed at prevention of dementia.
-
Ginkgo biloba is a dioecious tree with a history of use in traditional Chinese medicine.